HomeALM • VIE
Almirall SA
€8.81
Nov 29, 5:50:06 PM GMT+1 · EUR · VIE · Disclaimer
StockAT listed security
Previous close
€8.74
Day range
€8.79 - €8.84
Year range
€7.92 - €9.94
Market cap
1.82B EUR
Avg Volume
4.00
P/E ratio
-
Dividend yield
2.09%
Primary exchange
BME
CDP Climate Change Score
A-
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Sep 2024Y/Y change
Revenue
231.12M10.44%
Operating expense
90.74M7.23%
Net income
-8.19M-616.72%
Net profit margin
-3.54-565.79%
Earnings per share
EBITDA
45.19M-11.73%
Effective tax rate
-389.83%
Total assets
Total liabilities
(EUR)Sep 2024Y/Y change
Cash and short-term investments
343.10M37.29%
Total assets
2.31B-1.92%
Total liabilities
839.20M2.30%
Total equity
1.47B
Shares outstanding
213.47M
Price to book
1.27
Return on assets
0.23%
Return on capital
0.29%
Net change in cash
(EUR)Sep 2024Y/Y change
Net income
-8.19M-616.72%
Cash from operations
39.79M667.72%
Cash from investing
34.32M165.79%
Cash from financing
-10.36M-29.76%
Net change in cash
63.75M194.91%
Free cash flow
125.43M222.79%
About
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944. In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology. With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Founded
1944
Employees
1,996
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu